HEPASIN gouttes foie-bile buvable 50 ml

7680674240013 CH-67424 20.01.0.
HEPASIN gouttes foie-bile buvable 50 ml
HEPASIN gouttes foie-bile buvable 50 ml
HEPASIN gouttes foie-bile buvable 50 ml
1 / 3
google

Details

Product number
6742401
CPT
-
Packaging group
50
Unit
ml
Composition
silybum marianum (HAB) TM 0.4 ml, cynara scolymus ex herba TM (HAB 3a) 0.2 ml, artemisia absinthium (HAB) TM 0.2 ml, chelidonium majus (HAB) D1 0.1 ml, fumaria officinalis (HAB) TM 0.1 ml, aqua purificata, ethanolum 96 per centum, ad solutionem pro 1 ml, corresp. 31 guttae, corresp. ethanolum 64 % V/V.

Articles (1)

Hepasin Leber-Galletropfen, Tropfen zum Einnehmen
Tropfen zum Einnehmen
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/05/2025
Patient information leaflet
Français
07/05/2025
Patient information leaflet
Italien
07/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.4 ML Substance Wirkstoff (Principe actif)
(N/A)
0.2 ML Substance Wirkstoff (Principe actif)
(N/A)
0.2 ML Substance Wirkstoff (Principe actif)
(N/A)
0.1 ML Substance Wirkstoff (Principe actif)
(N/A)
0.1 ML Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Herbamed AG

9004 St. Gallen

Authorization information

Swissmedic authorization number
67424
Drug name
Hepasin Leber-Galletropfen, Tropfen zum Einnehmen
Galenic form
TROF
Authorization status
Z
Dispensation category
D
First authorization
12/01/2024
Authorization expiration date
11/01/2029
IT number
20.01.0.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild unterstützend bei Leber- und Galleleiden oder Fehlfunktion der Gallenblase.

Packaging details

Description (FR)
HEPASIN gouttes foie-bile buvable 50 ml
Description (DE)
HEPASIN Leber-Galletropfen zum Einnehmen 50 ml
Market launch
12/01/2024
Narcotic (BTM)
No